Skip to main content

Advertisement

SpringerLink
Log in

Post-TACE Combination Therapy of Heparin and Octreotide Results in Decreased Tumor Metastasis in Extrahepatic Tumorigenesis

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Primary hepatocarcinoma is the most common type of malignant tumor and a leading cause of cancer mortality. Standard treatment for patients with advanced primary hepatocarcinoma for whom surgery is not recommended includes transcatheter arterial chemoembolization (TACE). Within these patients 44% develop metastasis within 1 year. Thus, understanding the events underlying the recurrent tumors and developing therapies in conjunction with TACE would be of great benefit. Reducing tumor angiogenesis by combining the somatostatin analog octreotide with small doses of heparin is one approach in decreasing metastasis rates by targeting VEGF and heparinase, respectively. Given this, we investigated whether a heparin and octreotide combination treatment administered post-TACE would decrease the tumor metastasizing rate in primary hepatocarcinoma. A total of 147 patients diagnosed with primary hepatocarcinoma were admitted to the study and received 2–4 TACE treatments and were monitored for 1 year. Of these 84 received the heparin plus octreotide combination treatment and 63 did not (control group). All patients were monitored for adverse reactions, coagulation ability, and tumor metastasis. We found a significant decrease in the incidence of tumor metastasis in patients receiving the combination treatment post-TACE for up to 1 year with no significant toxic or adverse effects. Thus, we propose using the combination treatment of heparin and octreotide post-TACE in the treatment of recurrent tumorigenesis in primary hepatocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dank, M. (2010). Treatment of primary hepatocellular carcinoma. Orvosi Hetilap, 151(36), 1445–1449.

    Article  PubMed  Google Scholar 

  2. Xiong, Z. P., Yang, S. R., Liang, Z. Y., et al. (2004). Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Hepatobiliary and Pancreatic Disease International, 3, 386–390.

    CAS  Google Scholar 

  3. Guan, Y. S., & Liu, Y. (2006). Interventional treatments for hepatocellular carcinoma. Hepatobiliary and Pancreatic Disease International, 5(4), 495–500.

    Google Scholar 

  4. Takayasu, K., Arii, S., Ikai, I., et al. (2006). Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology, 131(2), 461.

    Article  PubMed  CAS  Google Scholar 

  5. Zhang, J. W., Feng, X. Y., Liu, H. Q., Yao, Z. W., Yang, Y. M., Liu, B., et al. (2010). CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE. World Journal of Gastroenterology, 16, 2038–2045.

    Article  PubMed  Google Scholar 

  6. Zhou, X. D. (2002). Recurrence and metastasis of hepatocellular carcinoma: Progress and prospects. Hepatobiliary and Pancreatic Disease International, 1, 35–41.

    Google Scholar 

  7. Tang, Z. (1999). Recurrence and metastasis. A focus of the study of primary liver cancer. Chinese Journal of Hepatobiliary Surgery, 5, 3–5.

    Google Scholar 

  8. TenCate, H., Timmerman, J. J., & Levi, M. (1999). The pathophysiology of disseminated intravascular coagulation. Thrombosis and Haemostasis, 82, 82–713.

    Google Scholar 

  9. Zheng, Q., Tang, Z., & Xue, Q. (1998). Effect of heparins on tumor growth and metastasis in human liver cancer metastasis in nude mice model. Journal of Chinese Hepatology, 6, 151–152.

    Google Scholar 

  10. Drixler, F. A., Borel, R. I. H. M., Ritchie, E. D., et al. (2000). Continuous administration of angiostatin inhibits accelerate growth of colorectal liver metastases after partial hepatectomy. Cancer Research, 60(6), 1761–1765.

    PubMed  CAS  Google Scholar 

  11. Sanderson, R. D., Yang, Y., et al. (2004). Heparan sulfate proteogly-cans and heparanase partners in osteolytic tumor growth and metastasis. Matrix Biology, 23(6), 341–352.

    Article  PubMed  CAS  Google Scholar 

  12. Qu, Y., Zhang, S., Xu, X., Wang, H., et al. (2009). Octreotide inhibits choroidal neovascularization in rats. Ophthalmic Research, 42(1), 36–42.

    Article  PubMed  CAS  Google Scholar 

  13. Huang, J., Duan, Q., Fan, P., et al. (2010). Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma. Cell Biochemistry and Biophysics, 59(2), 127–132.

    Article  Google Scholar 

  14. Jia, W. D., Xu, G. L., Wang, W., et al. (2009). A somatostatin analogue, octreotide, inhibits the occurrence of second primary tumors and lung metastasis after resection of hepatocellular carcinoma in mice. Tohoku Journal of Experimental Medicine, 218(2), 155–160.

    Article  PubMed  CAS  Google Scholar 

  15. Jia, W. D., Xu, G. L., Xu, R. N., et al. (2003). Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts. Journal of Cancer Research and Clinical Oncology, 129(6), 327–334.

    Article  PubMed  CAS  Google Scholar 

  16. Professional committee of Chinese anti-cancer association of liver cancer. (2001). Clinical diagnostic/staging criteria of primary liver cancer. Zhonghua Gan Zang Bing Za Zhi, 9(6), 324.

    Google Scholar 

  17. Zhou J (2003). Practical Tumor Sciences. Medicine (2nd edition) Beijing: People’s Medical Publishing House. p 47.

  18. Trotti, A., Byhardt, R., Stetz, J., Gwede, C., Corn, B., Fu, K., et al. (2000). Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 47(1), 13–47.

    Article  PubMed  CAS  Google Scholar 

  19. Cohen, E., Atzmon, R., Vlodavsky, I., & Ilan, N. (2005). Heparanase processing by lysosomal/endosomal protein preparation. FEBS Letters, 579(11), 2334–2338.

    Article  PubMed  CAS  Google Scholar 

  20. Vlodavsky, I., & Friedmann, Y. (2001). Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. Journal of Clinical Investigation, 108(3), 341–347.

    PubMed  CAS  Google Scholar 

  21. Goldshmidt, O., Zcharia, E., Abramovitch, R., et al. (2002). Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proceedings of National Academy of Sciences USA, 99(15), 10031–10036.

    Article  CAS  Google Scholar 

  22. Cui, J., Dong, B. W., Liang, P., Yu, X. L., & Yu, D. J. (2004). Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection. World Journal of Gastroenterology, 10(10), 1533–1536.

    PubMed  CAS  Google Scholar 

  23. Xu, G., Fu, B., & Xu, R. (2004). Effect of somatostatin on expression and synthesis of vascular endothelial growth factor of human hepatoma cell line BEC-7420. Chinese Journal of Surgery, 11(22), 1527–1538.

    Google Scholar 

  24. Liu, J., & Yi, J. (2007). Relationship between the changes of VEGF level and dendritic cells in peripheral blood of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization. Journal of Huazhong University of Science and Technology [Medical Sciences], 27(1), 58–60.

    Article  CAS  Google Scholar 

  25. Li, X. R., Yang, Z. F., & Yi, J. L. (2006). Expression of CD44v6 and vascular endothelial growth factor in hepatocellular carcinoma after transcatheter hepatic arterial chemoembolization. Shijie Huaren Xiaohua Zazhi, 14(13), 1305–1308.

    CAS  Google Scholar 

  26. Xiong, Z. P., Yang, S. R., Liang, Z. Y., et al. (2004). Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Hepatobiliary and Pancreatic Disease International, 3(3), 386–390.

    CAS  Google Scholar 

  27. Smorenburg, S. M., & Van Noorden, C. J. (2001). The complex effects of heparins on cancer progression and metastasis in experimental studies. Pharmacological Reviews, 53(1), 93–105.

    PubMed  CAS  Google Scholar 

  28. Kragh, M., Binderup, L., Vig Hjarnaa, P. J., et al. (2005). Non anti-coagulant heparin inhibits metastasis but not primary tumor growth. Oncology Reports, 14(1), 99–104.

    PubMed  CAS  Google Scholar 

  29. Yoshitomi, Y., Nakanishi, H., Kusano, Y., et al. (2004). Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity. Cancer Letters, 207(2), 165–174.

    Article  PubMed  CAS  Google Scholar 

  30. Wang, C. H., Tang, C. W., Liu, C. L., et al. (2003). Inhibitory effect of octreotide on gastric cancer growth via MAPK pathway. World Journal of Gastroenterology, 9(9), 1904–1908.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anhui Tumor Hospital, Hefei, 230031, China

    Kehai Feng, Pingsheng Fan, Gaofei Fan, Shoumei Yang, Tengyue Zhang, Qiang Wei & Liting Qian

  2. The Provincial Hospital of Anhui, Hefei, 230001, China

    Weidong Jia

Authors
  1. Weidong Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kehai Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pingsheng Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gaofei Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shoumei Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tengyue Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qiang Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Liting Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pingsheng Fan.

Additional information

Weidong Jia and Kehai Feng are co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jia, W., Feng, K., Fan, P. et al. Post-TACE Combination Therapy of Heparin and Octreotide Results in Decreased Tumor Metastasis in Extrahepatic Tumorigenesis. Cell Biochem Biophys 62, 35–40 (2012). https://doi.org/10.1007/s12013-011-9255-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-011-9255-8

Keywords

Search

Navigation